{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:10:57Z","timestamp":1794355857700,"version":"4.9.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016939","name":"Myriad Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016939","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Although several hereditary cancer predisposition genes have been implicated in pancreatic ductal adenocarcinoma (PDAC) susceptibility, gene-specific risks are not well defined and are potentially biased because of the design of previous studies. More precise and unbiased risk estimates can result in screening and prevention better tailored to genetic findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a retrospective analysis of 676\u200a667 individuals, 2445 of whom had a personal diagnosis of PDAC, who received multigene panel testing between 2013 and 2020 from a single laboratory. Clinical data were obtained from test requisition forms. Multivariable logistic regression models determined the increased risk of PDAC because of pathogenic variants (PVs) in various genes as adjusted odds ratios (ORs) with 95% confidence intervals (CIs). Multivariable odds ratios were adjusted for age, personal and\/or family cancer history, and ancestry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 11.1% of patients with PDAC had a PV. Statistically significantly elevated PDAC risk (2-sided P\u2009&amp;lt;\u2009.05) was observed for CDK2NA (p16INK4a) (OR = 8.69, 95% CI = 4.69 to 16.12), ATM (OR = 3.44, 95% CI = 2.58 to 4.60), MSH2 (OR = 3.17, 95% CI = 1.70 to 5.91), PALB2 (OR = 3.09, 95% CI = 2.02 to 4.74), BRCA2 (OR = 2.55, 95% CI = 1.99 to 3.27), and BRCA1 (OR = 1.62, 95% CI = 1.07 to 2.43).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study provides PDAC risk estimates for 6 genes commonly included in multigene panel testing for hereditary cancer risk. These estimates are lower than those from previous studies, possibly because of adjustment for family history, and support current recommendations for germline testing in all PDAC patients, regardless of a personal or family history of cancer.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jnci\/djac069","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T11:22:22Z","timestamp":1650367342000},"page":"996-1002","source":"Crossref","is-referenced-by-count":23,"title":["Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes"],"prefix":"10.1093","volume":"114","author":[{"given":"Anna","family":"Gardiner","sequence":"first","affiliation":[{"name":"Myriad Genetics, Inc , Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-6388","authenticated-orcid":false,"given":"John","family":"Kidd","sequence":"additional","affiliation":[{"name":"Myriad Genetics, Inc , Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Elias","sequence":"additional","affiliation":[{"name":"Myriad Genetic Laboratories, Inc , Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Young","sequence":"additional","affiliation":[{"name":"Myriad Genetic Laboratories, Inc , Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Mabey","sequence":"additional","affiliation":[{"name":"Myriad Genetics, Inc , Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Taherian","sequence":"additional","affiliation":[{"name":"Myriad Genetic Laboratories, Inc , Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6901-9664","authenticated-orcid":false,"given":"Shelly","family":"Cummings","sequence":"additional","affiliation":[{"name":"Myriad Genetic Laboratories, Inc , Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mokenge","family":"Malafa","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Oncology, Moffit Cancer Center , Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0930-9683","authenticated-orcid":false,"given":"Eric","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Myriad Genetic Laboratories, Inc , Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B","family":"Permuth","sequence":"additional","affiliation":[{"name":"Departments of Cancer Epidemiology and Gastrointestinal Oncology, Moffit Cancer Center , Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"2022071217505852700_djac069-B1","year":"2020"},{"issue":"30","key":"2022071217505852700_djac069-B2","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","article-title":"Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma","volume":"35","author":"Shindo","year":"2017","journal-title":"J Clin Oncol"},{"issue":"17","key":"2022071217505852700_djac069-B3","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1200\/JCO.2015.64.0730","article-title":"Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European Expert Centers","volume":"34","author":"Vasen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"21","key":"2022071217505852700_djac069-B4","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.3748\/wjg.v23.i21.3765","article-title":"Role of surgery in pancreatic cancer","volume":"23","author":"Buanes","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2022071217505852700_djac069-B5","author":"Daly"},{"issue":"5","key":"2022071217505852700_djac069-B6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jama.2019.10232","article-title":"Screening for pancreatic cancer: US preventive services task force reaffirmation recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"8","key":"2022071217505852700_djac069-B7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00535-021-01806-y","article-title":"A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer","volume":"56","author":"Astiazaran-Symonds","year":"2021","journal-title":"J Gastroenterol"},{"issue":"24","key":"2022071217505852700_djac069-B8","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1002\/cncr.29664","article-title":"Identification of germline genetic mutations in patients with pancreatic cancer","volume":"121","author":"Salo-Mullen","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"2022071217505852700_djac069-B9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"2022071217505852700_djac069-B10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.34.10.1394","article-title":"Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis","volume":"34","author":"Giardiello","year":"1993","journal-title":"Gut"},{"issue":"4","key":"2022071217505852700_djac069-B11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1158\/1940-6207.CAPR-20-0448","article-title":"Germline pathogenic variants in the Ataxia Telangiectasia Mutated (ATM) gene are associated with high and moderate risks for multiple cancers","volume":"14","author":"Hall","year":"2021","journal-title":"AACR Cancer Prev Res"},{"issue":"23","key":"2022071217505852700_djac069-B12","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"2022071217505852700_djac069-B13","first-page":"1","article-title":"Multigene hereditary cancer panels reveal high-risk pancreatic cancer susceptibility genes","volume":"2","author":"Hu","year":"2018","journal-title":"J Clin Oncol Precis Oncol"},{"issue":"1","key":"2022071217505852700_djac069-B14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"issue":"2","key":"2022071217505852700_djac069-B15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"2022071217505852700_djac069-B16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.gastro.2020.03.088","article-title":"AGA clinical practice update on pancreas cancer screening in high-risk individuals: expert review","volume":"159","author":"Aslanian","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"2022071217505852700_djac069-B17","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database","volume":"67","author":"Moller","year":"2018","journal-title":"Gut"},{"key":"2022071217505852700_djac069-B18","author":"Gupta"},{"issue":"7","key":"2022071217505852700_djac069-B19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families","volume":"38","author":"Yang","year":"2020","journal-title":"J Clin Oncol"},{"issue":"8","key":"2022071217505852700_djac069-B20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF02303487","article-title":"The risk of gastrointestinal carcinoma in familial juvenile polyposis","volume":"5","author":"Howe","year":"1998","journal-title":"Ann Surg Oncol"},{"key":"2022071217505852700_djac069-B21","year":"2020"},{"issue":"6","key":"2022071217505852700_djac069-B22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ajg.2009.725","article-title":"High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations","volume":"105","author":"van Lier","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"2022071217505852700_djac069-B23","first-page":"1","article-title":"Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women","volume":"2017","author":"Kurian","year":"2017","journal-title":"J Clin Oncol Precis Oncol"},{"key":"2022071217505852700_djac069-B24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-015-1224-y","article-title":"Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk","volume":"15","author":"Judkins","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"2022071217505852700_djac069-B25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12920-019-0587-3","article-title":"Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing","volume":"12","author":"Mancini-DiNardo","year":"2019","journal-title":"BMC Med Genomics"},{"issue":"3","key":"2022071217505852700_djac069-B26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/cge.12315","article-title":"A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes","volume":"86","author":"Eggington","year":"2014","journal-title":"Clin Genet"},{"issue":"5","key":"2022071217505852700_djac069-B27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2022071217505852700_djac069-B28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1200\/PO.20.00020","article-title":"Impact of a cancer gene variant reclassification program over a 20-year period","volume":"4","author":"Esterling","year":"2020","journal-title":"J Clin Oncol Precis Oncol"},{"issue":"5","key":"2022071217505852700_djac069-B29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes - association analysis in more than 113,000 women","volume":"384","author":"Dorling","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"2022071217505852700_djac069-B30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"key":"2022071217505852700_djac069-B31","volume-title":"Modern Epidemiology","author":"Rothman","year":"2008"},{"issue":"1","key":"2022071217505852700_djac069-B32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1158\/1055-9965.EPI-15-0455","article-title":"Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients","volume":"25","author":"Hu","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"2022071217505852700_djac069-B33","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1002\/cam4.2973","article-title":"Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening","volume":"9","author":"Cremin","year":"2020","journal-title":"Cancer Med"},{"key":"2022071217505852700_djac069-B34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cancergen.2017.09.003","article-title":"Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories","volume":"218-219","author":"Rosenthal","year":"2017","journal-title":"Cancer Genet"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djac069\/43954790\/djac069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/7\/996\/44819112\/djac069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/7\/996\/44819112\/djac069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T12:56:15Z","timestamp":1727009775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/114\/7\/996\/6571816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4,21]]},"published-print":{"date-parts":[[2022,7,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djac069","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,4,21]]}}}